ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998